Literature DB >> 29086457

Passive Stretch Induces Structural and Functional Maturation of Engineered Heart Muscle as Predicted by Computational Modeling.

Oscar J Abilez1,2,3,4, Evangeline Tzatzalos1,2, Huaxiao Yang1,2, Ming-Tao Zhao1,2, Gwanghyun Jung1,5, Alexander M Zöllner6, Malte Tiburcy7,8, Johannes Riegler1,2, Elena Matsa1,2, Praveen Shukla1,2, Yan Zhuge1,2, Tony Chour1,2, Vincent C Chen9, Paul W Burridge1,2, Ioannis Karakikes1,2, Ellen Kuhl1,3,6, Daniel Bernstein1,5, Larry A Couture9,10, Joseph D Gold1,2, Wolfram H Zimmermann7,8, Joseph C Wu1,2,3,4.   

Abstract

The ability to differentiate human pluripotent stem cells (hPSCs) into cardiomyocytes (CMs) makes them an attractive source for repairing injured myocardium, disease modeling, and drug testing. Although current differentiation protocols yield hPSC-CMs to >90% efficiency, hPSC-CMs exhibit immature characteristics. With the goal of overcoming this limitation, we tested the effects of varying passive stretch on engineered heart muscle (EHM) structural and functional maturation, guided by computational modeling. Human embryonic stem cells (hESCs, H7 line) or human induced pluripotent stem cells (IMR-90 line) were differentiated to hPSC-derived cardiomyocytes (hPSC-CMs) in vitro using a small molecule based protocol. hPSC-CMs were characterized by troponin+ flow cytometry as well as electrophysiological measurements. Afterwards, 1.2 × 106 hPSC-CMs were mixed with 0.4 × 106 human fibroblasts (IMR-90 line) (3:1 ratio) and type-I collagen. The blend was cast into custom-made 12-mm long polydimethylsiloxane reservoirs to vary nominal passive stretch of EHMs to 5, 7, or 9 mm. EHM characteristics were monitored for up to 50 days, with EHMs having a passive stretch of 7 mm giving the most consistent formation. Based on our initial macroscopic observations of EHM formation, we created a computational model that predicts the stress distribution throughout EHMs, which is a function of cellular composition, cellular ratio, and geometry. Based on this predictive modeling, we show cell alignment by immunohistochemistry and coordinated calcium waves by calcium imaging. Furthermore, coordinated calcium waves and mechanical contractions were apparent throughout entire EHMs. The stiffness and active forces of hPSC-derived EHMs are comparable with rat neonatal cardiomyocyte-derived EHMs. Three-dimensional EHMs display increased expression of mature cardiomyocyte genes including sarcomeric protein troponin-T, calcium and potassium ion channels, β-adrenergic receptors, and t-tubule protein caveolin-3. Passive stretch affects the structural and functional maturation of EHMs. Based on our predictive computational modeling, we show how to optimize cell alignment and calcium dynamics within EHMs. These findings provide a basis for the rational design of EHMs, which enables future scale-up productions for clinical use in cardiovascular tissue engineering. Stem Cells 2018;36:265-277.
© 2017 AlphaMed Press.

Entities:  

Keywords:  Bioengineering; Calcium handling; Cardiac; Cardiomyocyte; Computational modeling; Engineered heart muscle; Heart; Pluripotent stem cells; Tissue engineering; Tissue regeneration

Mesh:

Year:  2017        PMID: 29086457      PMCID: PMC5785460          DOI: 10.1002/stem.2732

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  66 in total

1.  Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes.

Authors:  W H Zimmermann; C Fink; D Kralisch; U Remmers; J Weil; T Eschenhagen
Journal:  Biotechnol Bioeng       Date:  2000-04-05       Impact factor: 4.530

Review 2.  Engineered heart tissues and induced pluripotent stem cells: Macro- and microstructures for disease modeling, drug screening, and translational studies.

Authors:  Evangeline Tzatzalos; Oscar J Abilez; Praveen Shukla; Joseph C Wu
Journal:  Adv Drug Deliv Rev       Date:  2015-09-30       Impact factor: 15.470

3.  Regional myocardial work by strain Doppler echocardiography and LV pressure: a new method for quantifying myocardial function.

Authors:  Stig Urheim; Stein Inge Rabben; Helge Skulstad; Erik Lyseggen; Halfdan Ihlen; Otto A Smiseth
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-01-06       Impact factor: 4.733

4.  Tissue engineering of vascularized cardiac muscle from human embryonic stem cells.

Authors:  Oren Caspi; Ayelet Lesman; Yaara Basevitch; Amira Gepstein; Gil Arbel; Irit Huber Manhal Habib; Lior Gepstein; Shulamit Levenberg
Journal:  Circ Res       Date:  2007-01-11       Impact factor: 17.367

5.  Heart volume, myocardial volume and total capacity of the heart cavities in certain chronic heart diseases; a clinic, roentgenologic and patho-anatomic investigation of the problem of cardiac hypertrophy and dilatation and amount of residual blood of the heart.

Authors:  C E FRIEDMAN
Journal:  Acta Med Scand Suppl       Date:  1951

6.  Recapitulating maladaptive, multiscale remodeling of failing myocardium on a chip.

Authors:  Megan L McCain; Sean P Sheehy; Anna Grosberg; Josue A Goss; Kevin Kit Parker
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-28       Impact factor: 11.205

7.  Cardiac differentiation of human embryonic stem cells and their assembly into engineered heart muscle.

Authors:  Poh Loong Soong; Malte Tiburcy; Wolfram-Hubertus Zimmermann
Journal:  Curr Protoc Cell Biol       Date:  2012-06

8.  Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming.

Authors:  Paul W Burridge; Gordon Keller; Joseph D Gold; Joseph C Wu
Journal:  Cell Stem Cell       Date:  2012-01-06       Impact factor: 24.633

9.  Growth of engineered human myocardium with mechanical loading and vascular coculture.

Authors:  Nathaniel L Tulloch; Veronica Muskheli; Maria V Razumova; F Steven Korte; Michael Regnier; Kip D Hauch; Lil Pabon; Hans Reinecke; Charles E Murry
Journal:  Circ Res       Date:  2011-05-19       Impact factor: 17.367

10.  Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy.

Authors:  Ning Sun; Masayuki Yazawa; Jianwei Liu; Leng Han; Veronica Sanchez-Freire; Oscar J Abilez; Enrique G Navarrete; Shijun Hu; Li Wang; Andrew Lee; Aleksandra Pavlovic; Shin Lin; Rui Chen; Roger J Hajjar; Michael P Snyder; Ricardo E Dolmetsch; Manish J Butte; Euan A Ashley; Michael T Longaker; Robert C Robbins; Joseph C Wu
Journal:  Sci Transl Med       Date:  2012-04-18       Impact factor: 17.956

View more
  47 in total

1.  Optimizing mechanical stretching protocols for hypertrophic and anti-apoptotic responses in cardiomyocyte-like H9C2 cells.

Authors:  Evangelos Zevolis; Anastassios Philippou; Athanasios Moustogiannis; Antonios Chatzigeorgiou; Michael Koutsilieris
Journal:  Mol Biol Rep       Date:  2021-01-04       Impact factor: 2.316

Review 2.  Cardiomyocyte Maturation: New Phase in Development.

Authors:  Yuxuan Guo; William T Pu
Journal:  Circ Res       Date:  2020-04-09       Impact factor: 17.367

Review 3.  ESC Working Group on Cellular Biology of the Heart: position paper for Cardiovascular Research: tissue engineering strategies combined with cell therapies for cardiac repair in ischaemic heart disease and heart failure.

Authors:  Rosalinda Madonna; Linda W Van Laake; Hans Erik Botker; Sean M Davidson; Raffaele De Caterina; Felix B Engel; Thomas Eschenhagen; Francesco Fernandez-Aviles; Derek J Hausenloy; Jean-Sebastien Hulot; Sandrine Lecour; Jonathan Leor; Philippe Menasché; Maurizio Pesce; Cinzia Perrino; Fabrice Prunier; Sophie Van Linthout; Kirsti Ytrehus; Wolfram-Hubertus Zimmermann; Peter Ferdinandy; Joost P G Sluijter
Journal:  Cardiovasc Res       Date:  2019-03-01       Impact factor: 10.787

Review 4.  The Role of Reactive Oxygen Species in In Vitro Cardiac Maturation.

Authors:  Nima Momtahan; Cody O Crosby; Janet Zoldan
Journal:  Trends Mol Med       Date:  2019-05-09       Impact factor: 11.951

5.  Epigenetic Priming of Human Pluripotent Stem Cell-Derived Cardiac Progenitor Cells Accelerates Cardiomyocyte Maturation.

Authors:  Mitch Biermann; Wenxuan Cai; Di Lang; Jack Hermsen; Luke Profio; Ying Zhou; Andras Czirok; Dona G Isai; Brett N Napiwocki; Adriana M Rodriguez; Matthew E Brown; Marites T Woon; Annie Shao; Tianxiao Han; Donglim Park; Timothy A Hacker; Wendy C Crone; William J Burlingham; Alexey V Glukhov; Ying Ge; Timothy J Kamp
Journal:  Stem Cells       Date:  2019-05-14       Impact factor: 6.277

Review 6.  The Driving Force: Nuclear Mechanotransduction in Cellular Function, Fate, and Disease.

Authors:  Melanie Maurer; Jan Lammerding
Journal:  Annu Rev Biomed Eng       Date:  2019-03-27       Impact factor: 9.590

7.  Strategies for Improving the Maturity of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.

Authors:  Chengyi Tu; Benjamin S Chao; Joseph C Wu
Journal:  Circ Res       Date:  2018-08-17       Impact factor: 17.367

Review 8.  Induced pluripotent stem cells as a platform to understand patient-specific responses to opioids and anaesthetics.

Authors:  Detlef Obal; Joseph C Wu
Journal:  Br J Pharmacol       Date:  2020-08-27       Impact factor: 8.739

9.  Systems-Wide Approaches in Induced Pluripotent Stem Cell Models.

Authors:  Edward Lau; David T Paik; Joseph C Wu
Journal:  Annu Rev Pathol       Date:  2018-10-31       Impact factor: 23.472

10.  Human perinatal stem cell derived extracellular matrix enables rapid maturation of hiPSC-CM structural and functional phenotypes.

Authors:  Travis Block; Jeffery Creech; Andre Monteiro da Rocha; Milos Marinkovic; Daniela Ponce-Balbuena; Eric N Jiménez-Vázquez; Sy Griffey; Todd J Herron
Journal:  Sci Rep       Date:  2020-11-04       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.